Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 137.22 | 157.62 | 115.50 | 106.31 | 76.76 |
| Operating profit | 1.00 | 21.14 | 18.77 | 5.58 | 4.28 |
| Interest | 0.35 | 0.46 | 0.29 | 0.38 | 0.74 |
| Gross profit | 1.31 | 20.86 | 18.80 | 5.42 | 3.58 |
| EPS (Rs) | 1.37 | 49.45 | 43.50 | 12.12 | 7.24 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.66 | 0.18 | 0.33 | 0.23 | 0.04 |
| Stock adjustment | 4.17 | -12.35 | -0.85 | 0.52 | 3.31 |
| Raw material | 127.76 | 144.42 | 93.14 | 97.10 | 66.72 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.00 | 0.84 | 1.00 | 0.78 | 0.58 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.29 | 3.57 | 3.45 | 2.35 | 1.87 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.33 | 0.32 | 0.30 | 0.29 | 0.23 |
| Taxation | 0.57 | 5.27 | 5.03 | 1.39 | 1.11 |
| Net profit / loss | 0.42 | 15.28 | 13.44 | 3.74 | 2.24 |
| Extra ordinary item | - | - | -0.02 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 0.73 | 13.41 | 16.25 | 5.25 | 5.57 |
| GPM (%) | .95 | 13.22 | 16.23 | 5.09 | 4.66 |
| NPM (%) | 0.31 | 9.68 | 11.61 | 3.51 | 2.91 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis